Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orchid 1
2023-503516-32-00Phase 2Completed
- Sponsor
- MC2 Therapeutics
- Start
- Oct 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Kraurosis vulvae comparing MC2-25 cream with MC2-25 vehicle (2 arms). Primary endpoint: Mean change in weekly mean WI-NRS from baseline to week 12. Started Oct 2023; status: completed.
02
Drugs
MC2-25
03
Conditions
Kraurosis vulvae
Beyond the preview
Go deeper on 2023-503516-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503516-32-00.